Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

$0.96
+0.04 (+4.32%)
(As of 05/13/2024 ET)

Recent Biodexa Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/02/2024
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/02/2024
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/02/2024
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/02/2024
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
04/30/2024
12:11 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
8:47 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form POS AM
04/29/2024
8:49 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form POS AM
04/29/2024
8:55 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form POS AM
04/26/2024
7:45 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
7:19 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
7:24 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/27/2024
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
03/28/2024
5:00 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
03/18/2024
3:31 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
02/28/2024
3:14 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
02/28/2024
3:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
02/28/2024
3:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
02/23/2024
12:25 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:47 PM
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Ionic Ventures, LLC (Filed by)
Form SC 13G/A
02/14/2024
1:42 PM
ARMISTICE CAPITAL, LLC (Filed by)
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
1:14 PM
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G/A
02/12/2024
3:30 PM
Bigger Capital, LLC (Filed by)
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Form SC 13G
01/22/2024
7:51 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/29/2023
11:10 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/28/2023
3:30 PM
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Cavalry Fund I LP (Filed by)
Form SC 13G
12/26/2023
3:51 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
12/26/2023
3:53 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
12/26/2023
3:53 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
12/21/2023
3:30 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
3:54 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B4
12/18/2023
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
12/14/2023
4:20 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1/A
12/06/2023
4:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1/A
12/06/2023
3:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/27/2023
7:57 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1/A
11/27/2023
7:45 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2023
3:06 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
10/03/2023
9:10 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/29/2023
3:45 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2023
3:23 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/24/2023
3:21 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (Ad)

While gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.

Click to watch this device in action
07/24/2023
3:22 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/24/2023
7:07 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2023
7:27 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2023
3:43 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2023
10:52 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2023
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/26/2023
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/22/2023
3:33 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2023
3:30 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form POS AM
06/20/2023
7:16 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2023
7:41 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
06/15/2023
3:51 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/14/2023
7:35 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2023
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/02/2023
5:00 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/01/2023
6:27 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2023
3:24 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/25/2023
8:53 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K/A
05/25/2023
8:54 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B5
05/25/2023
4:25 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B5
05/25/2023
3:39 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form POS AM
05/25/2023
3:46 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K/A
05/24/2023
4:29 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/18/2023
8:00 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BDRX) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners